Anesthesiology, Pain Medicine · Arlington, TX
NPI
1073747150
Since 2009
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1119 W Randol Mill Rd # 100
Arlington, TX, 76012
Phone (817) 860-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$416K
12,034 services
Medicare patients, 2024
464
Average age 73
Drug cost, 2024
$646K
11,267 prescriptions
Company payments, 2025
$771
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Don Escarzega-Phan was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 4,273 times for 260 patients. In total Don Escarzega-Phan billed 12,034 services in 46 codes, and Medicare paid $416K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 4,273 | 260 | $0.78 | $3,322 |
| J1170 Injection, hydromorphone, up to 4 mg | Office | 1,987 | 12 | $3.18 | $6,328 |
| 99213 Office E&M - Established | Office | 1,929 | 419 | $59.99 | $116K |
| J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | Office | 1,321 | 13 | $9.11 | $12K |
| 99214 Office E&M - Established | Office | 435 | 219 | $86.70 | $38K |
| 62323 Nerve Block Injection - Back | Office | 284 | 156 | $180.19 | $51K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 273 | 158 | $194.77 | $53K |
| 80307 Drug Tests | Office | 272 | 158 | $60.90 | $17K |
| 20610 Joint Injection | Office | 125 | 63 | $51.88 | $6,485 |
| 77002 Imaging - Miscellaneous | Office | 108 | 59 | $80.69 | $8,714 |
| 64493 Nerve Block Injection - Back | Office | 105 | 64 | $169.37 | $18K |
| 99204 Office E&M - New | Office | 102 | 102 | $115.01 | $12K |
| 64494 Nerve Block Injection - Back | Office | 100 | 61 | $88.80 | $8,880 |
| 62370 Musculoskeletal | Office | 92 | 25 | $63.44 | $5,836 |
| 62321 Nerve Block Injection - Back | Office | 83 | 58 | $180.36 | $15K |
By year: 2022 $428K for 11,063 services; 2023 $379K for 11,983 services; 2024 $416K for 12,034 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 273 | 158 | $194.77 | $53K |
| 80307 Drug Tests | 272 | 158 | $60.90 | $17K |
Medicare prescription drug claims, 2024
In 2024, the drug Don Escarzega-Phan prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 3,142 prescriptions and refills. In total Don Escarzega-Phan wrote 11,267 Medicare prescriptions that cost $646K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 3,142 | 3,142 | 699 | $124K |
| Gabapentin Generic | 753 | 926 | 197 | $11K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 658 | 658 | 155 | $22K |
| Dexamethasone Generic | 645 | 645 | 464 | $3,800 |
| Tizanidine Hcl Generic | 633 | 707 | 187 | $7,687 |
| Pregabalin Generic | 525 | 574 | 141 | $12K |
| Tramadol Hcl Generic | 510 | 511 | 152 | $5,081 |
| Oxycodone Hcl Generic | 492 | 492 | 95 | $8,785 |
| Methocarbamol Generic | 358 | 388 | 106 | $5,913 |
| Cyclobenzaprine Hcl Generic | 336 | 373 | 89 | $4,766 |
| Celecoxib Generic | 272 | 315 | 85 | $3,837 |
| Buprenorphine Generic | 217 | 217 | 65 | $56K |
| Lidocaine Generic | 194 | 206 | 60 | $14K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 170 | 170 | 50 | $4,002 |
| Hydromorphone Hcl Generic | 166 | 166 | 47 | $2,613 |
Brand drugs: 489 claims; generic drugs: 10,778 claims; opioid claims: 5,831.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Don Escarzega-Phan $771 ($771 in general payments such as food, travel and fees) from 15 companies. The largest payer was Collegium Pharmaceutical, Inc. with $275.
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. COLL | 13 | $275 |
| Pfizer Inc. PFE | 8 | $143 |
| Abbott Laboratories ABT | 3 | $52.77 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $44.71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $33.38 |
| Medtronic, Inc. MDT | 2 | $33.31 |
| Averitas Pharma Inc. | 1 | $31.67 |
| Azurity Pharmaceuticals, Inc. | 2 | $31.4 |
| Tonix Medicines, Inc. | 1 | $21.19 |
| Valinor Pharma, LLC | 1 | $21.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.